We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+29.7%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.09B
AUM Growth
+$568M
(+109%)
Cap. Flow
+$422M
Cap. Flow
% of AUM
38.69%
Top 10 Holdings %
Top 10 Hldgs %
23.6%
Holding
197
New
132
Increased
39
Reduced
16
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$26.1M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$20M |
| 3 |
Arvinas
ARVN
|
+$19.8M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$19.7M |
| 5 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aprea Therapeutics
APRE
|
+$18.2M |
| 2 |
KYNB
Kyntra Bio
KYNB
|
+$12M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$10.7M |
| 4 |
Teladoc Health
TDOC
|
+$10.1M |
| 5 |
Biogen
BIIB
|
+$8.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.26% |
| 2 | Industrials | 4.93% |
| 3 | Technology | 1.47% |
| 4 | Energy | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Quest Diagnostics
DGX
$25.7B
| $2.35M | 0.22% |
+20,600
| New | +$2.18M |
|
|
HOLX
77
DELISTED
Hologic
HOLX
| $2.25M | 0.21% |
+39,500
| New | +$1.94M |
|
78
Cooper Companies
COO
$14.1B
| $2.13M | 0.2% |
+30,000
| New | +$2.22M |
|
79
Humana
HUM
$43.7B
| $2.03M | 0.19% |
+5,225
| New | +$1.95M |
|
|
EXAS
80
DELISTED
Exact Sciences
EXAS
| $1.99M | 0.18% |
+22,900
| New | +$1.83M |
|
81
Steris
STE
$22.3B
| $1.98M | 0.18% |
+12,900
| New | +$1.96M |
|
|
CTLT
82
DELISTED
CATALENT, INC.
CTLT
| $1.73M | 0.16% |
+23,600
| New | +$1.6M |
|
83
Neurocrine Biosciences
NBIX
$16.8B
| $1.72M | 0.16% |
+14,100
| New | +$1.56M |
|
|
VAR
84
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.72M | 0.16% |
+14,000
| New | +$1.62M |
|
|
85
Biogen
BIIB
$30B
| $1.71M | 0.16% |
6,392
-29,600
| -82% | -$8.9M |
|
86
Revvity
RVTY
$12.6B
| $1.68M | 0.15% |
+17,100
| New | +$1.56M |
|
|
ABMD
87
DELISTED
Abiomed Inc
ABMD
| $1.64M | 0.15% |
+6,800
| New | +$1.37M |
|
|
HZNP
88
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.57M | 0.14% |
+28,300
| New | +$1.21M |
|
89
Bio-Techne
TECH
$11.2B
| $1.53M | 0.14% |
+23,200
| New | +$1.39M |
|
90
Dentsply Sirona
XRAY
$2.68B
| $1.49M | 0.14% |
+33,700
| New | +$1.43M |
|
91
Bio-Rad Laboratories Class A
BIO
$8.71B
| $1.45M | 0.13% |
+3,200
| New | +$1.41M |
|
92
Icon
ICLR
$12.6B
| $1.35M | 0.12% |
+8,000
| New | +$1.26M |
|
93
Elanco Animal Health
ELAN
$13.2B
| $1.32M | 0.12% |
+61,600
| New | +$1.36M |
|
94
Charles River Laboratories
CRL
$11.2B
| $1.31M | 0.12% |
+7,500
| New | +$1.2M |
|
95
Henry Schein
HSIC
$9.77B
| $1.28M | 0.12% |
+21,900
| New | +$1.22M |
|
96
Viatris
VTRS
$20.4B
| $1.28M | 0.12% |
+79,500
| New | +$1.29M |
|
97
QuidelOrtho
QDEL
$1.14B
| $1.27M | 0.12% |
+5,700
| New | +$893K |
|
98
Ionis Pharmaceuticals
IONS
$8.6B
| $1.19M | 0.11% |
+20,100
| New | +$1.12M |
|
99
Perrigo
PRGO
$1.4B
| $1.16M | 0.11% |
+21,000
| New | +$1.11M |
|
100
Avantor
AVTR
$9.32B
| $1.08M | 0.1% |
+63,500
| New | +$1.03M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Sectoral Asset Management held 197 positions worth $1.09B, up 109% from $521M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $422M of net new capital in Q2 2020, opening 132 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 401,158 shares worth $25.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 86% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Aprea Therapeutics, an estimated $18.2M trimmed.
- Sectoral Asset Management's largest Q2 2020 buy was Centene: 401,158 shares worth $25.5M.
- Sectoral Asset Management added most to Cardiovascular Systems, Inc. in Q2 2020, an estimated $18.2M increase.
- Sectoral Asset Management's biggest Q2 2020 reduction was Aprea Therapeutics, cutting an estimated $18.2M.
- Sectoral Asset Management fully exited Inspire Medical Systems in Q2 2020, selling an estimated $6.81M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $1.09B portfolio in Q2 2020.
- Sectoral Asset Management opened 132 new positions and closed 6 in Q2 2020.
- Sectoral Asset Management's portfolio value rose 109% quarter-over-quarter to $1.09B.
Based on Sectoral Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.